We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

October 5, 2009

IN RE: Androgel Antitrust Litigation (No. II)

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 11, 2015

    Drugmakers Fight FTC Bid For Privileged Antitrust Risk Docs

    AbbVie Products LLC and other drugmakers being sued by the Federal Trade Commission and private plaintiffs over patent pay-for-delay settlements for testosterone drug AndroGel have told a Georgia federal court to reject a bid that would force them to turn over details of their settlement negotiations.

9 other articles on this case. View all »

Parties

To view the parties, register now.